Breast cancer increased risk on women using combined oral contraceptive

被引:0
|
作者
Fenile, R. [1 ]
Nazario, A. C. P. [1 ]
Simoes, C. M. [1 ]
机构
[1] Univ Fed Sao Paulo, EPM, Sao Paulo, SP, Brazil
关键词
D O I
10.1158/1538-7445.SABCS16-P6-05-02
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-05-02
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes
    Bui, Kim Tam
    Wakefield, Claire E.
    Kasparian, Nadine A.
    Tyler, Janet
    Abbott, Jason
    Tucker, Kathy
    [J]. PSYCHO-ONCOLOGY, 2013, 22 (01) : 228 - 232
  • [2] Breast Cancer Risk Related to Combined Oral Contraceptive Use
    Graafland, Laura
    Abbott, Maura
    Accordino, Melissa
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (02): : 116 - 120
  • [3] Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
    Gabrick, DM
    Hartmann, LC
    Cerhan, JR
    Vierkant, RA
    Therneau, TM
    Vachon, CM
    Olson, JE
    Couch, FJ
    Anderson, KE
    Pankratz, VS
    Sellers, TA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (14): : 1791 - 1798
  • [4] Risk of Cancer with Combined Oral Contraceptive Use among Iranian Women
    Vaisy, Afasaneh
    Lotfinejad, Shirin
    Zhian, Faegh
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5517 - 5522
  • [5] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Sandra A. Norman
    Jesse A. Berlin
    Anita L. Weber
    Brian L. Strom
    Janet R. Daling
    Linda K. Weiss
    Polly A. Marchbanks
    Leslie Bernstein
    Lynda F. Voigt
    Jill A. McDonald
    Giske Ursin
    Jonathan M. Liff
    Ronald T. Burkman
    Kathleen E. Malone
    Michael S. Simon
    Suzanne G. Folger
    Dennis Deapen
    Phyllis A. Wingo
    Robert Spirtas
    [J]. Cancer Causes & Control, 2003, 14 : 933 - 943
  • [6] Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women
    Norman, SA
    Berlin, JA
    Weber, AL
    Strom, BL
    Daling, JR
    Weiss, LK
    Marchbanks, PA
    Bernstein, L
    Voigt, LF
    McDonald, JA
    Ursin, G
    Liff, JM
    Burkman, RT
    Malone, KE
    Simon, MS
    Folger, SG
    Deapen, D
    Wingo, PA
    Spirtas, R
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (10) : 933 - 943
  • [7] Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians
    Smrekar, Karly
    Lodise, Nicole M.
    [J]. NURSING FOR WOMENS HEALTH, 2022, 26 (03) : 242 - 249
  • [8] Oral contraceptive use and risk of breast cancer in middle-aged women
    Rossing, MA
    Stanford, JL
    Weiss, NS
    Habel, LA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (02) : 161 - 164
  • [9] Oral contraceptive use and the risk of breast cancer
    Casey, Petra M.
    Cerhan, James R.
    Pruthi, Sandhya
    [J]. MAYO CLINIC PROCEEDINGS, 2008, 83 (01) : 86 - 91
  • [10] Oral contraceptive formulation and risk of breast cancer
    Marchbanks, Polly A.
    Curtis, Kathryn M.
    Mandel, Michele G.
    Wilson, Hoyt G.
    Jeng, Gary
    Folger, Suzanne G.
    McDonald, Jill A.
    Daling, Janet R.
    Bernstein, Leslie
    Malone, Kathleen E.
    Wingo, Phyllis A.
    Simon, Michael S.
    Norman, Sandra A.
    Strom, Brian L.
    Ursin, Giske
    Weiss, Linda K.
    Burkman, Ronald T.
    Spirtas, Robert
    [J]. CONTRACEPTION, 2012, 85 (04) : 342 - 350